Aytu bioscience inc

Major-Pharmaceuticals

AYTU


373 Inverness Parkway
Englewood , CO 80112

Executive/
Director

Price

  • Last Close
  • $ 0.22
    $ +0.01 6.97 %
    Jan 5, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 2,621,067
  • Market Cap Full
  • $ 1.2M
  • Shares Outstanding
  • 5.6M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -84.2% -25% -71.4% 111.4% -5% 27.1% -22.9% 13.8% -
Q2 - 62300% -34.4% -56.2% 9.5% 4% -34.1% -36.1% - -
Q3 - -30.3% -66.1% -47.9% -39.1% 8% -42.5% -72.5% - -
Q4 -5% -63.2% -44.3% -70.4% -11.5% 402.5% -51.4% -0.5% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 13.8% - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%2426%-91%-98%33%470%-77%-87%14%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.39 0.48 -4.8 -0.5 -1.5 - - -1.93
Q2 - 2.27 - 42.5 -0.3 1.82 -3.48 -75 -0.97
Q3 - 1.17 1.76 -1.96 -0.32 -0.4 - - -1.48
Q4 - 0.55 0.89 -0.72 -0.12 -0.72 - -2.15 -
A 0 4.4 3.1 35 -1.2 -0.8 -3.5 -74 -5.1

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2017 2018 2019 2020 2021 2022
Mar - 5 10.5 23 17.9 30.3
Jun - 35.9 16.7 120.3 25.2 38.6
Sep - 1.8 17.7 125.8 27.6 62.4
Dec 4.4 8.6 20.7 127.9 28.1 3.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - 1.5
Fixed Asset Turnover - - 0.4 0.4 0.3
Total Asset Turnover - - 0.2 0.2 0.2
Leverage
Debt Ratio 0.2 0.1 0.2 - -
Debt – Equity Ratio 0.3 0.1 0.1 - -
Interest Coverage - - 2.8 -1.6 2.1
Equity multiplier 0.1 - - - 0.9